Want to join the conversation?
$PFE's antibody-drug conjugate (ADC) inotuzumab ozogamicin was given Breakthrough Therapy designation by FDA in acute lymphoblastic leukemia. ADC is a monoclonal antibody which binds with CD22 antigen and internalizes in cancer cells where calicheamicin is released which kills the cell. This status allows for more intensive guidance from the FDA.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.